GLP-1 Weight-Loss Boom Linked to Surge in Poison Control Calls

A new study found that calls to poison control centers involving popular GLP-1 weight-loss drugs climbed sharply after semaglutide was approved for obesity in 2021, with most cases linked to medication mistakes that could have been avoided.